Susan Cohn

Cancer Research Roundup: Child Care and Treatment, IBD-associated Colorectal Cancer, Ibrutinib, and Glioblastoma

March 14, 2014

The latest roundup of cancer research from UChicago highlights: a study showing how young mothers with breast cancer often don't follow through with needed radiation therapy; a link between inflammatory bowel disease and colorectal cancer; Ibrutinib's work at limiting cell proliferation in chronic lymphocytic leukemia; a prognostic tool for neuroblastoma; and testing bevacizumab in glioblastoma. [Read more]

ASCO Highlights UChicago’s Role in Top Cancer Advances of 2013

February 4, 2014

University of Chicago researchers contributed several articles over the past year that the American Society of Clinical Oncology identified as highlighting advances in research with the “greatest potential to improve patient care and quality of life.” ASCO’s annual selection of clinical cancer advances, now in its ninth year, documents important progress being made and highlights emerging trends. [Read more]

Adults are Eligible for Many Pediatric Clinical Trials

August 8, 2013

In an earlier post, I pointed out the relative lack of overlap between the cancer types seen in children and adults. But there are plenty of examples of cancers that afflict both age groups, most notably in the leukemias and lymphomas. In recognition of this fact, clinical trial protocols are being designed to include children and adults within the same clinical trial - something not historically done. [Read more]

Cancer Disparities at an Early Age

November 23, 2010

Racial disparities have been described for almost every type of cancer, with the gap in outcomes widening or holding steady between black and white patients in breast, prostate, colorectal, and lung cancers. Much debate has occurred over the causes [Read more]

A Big Leap for Neuroblastoma

September 30, 2010

Cancer successes are usually measured in months, not years. Large clinical trial on promising new treatments are celebrated when they show an average effect of a dozen weeks, and extension of life that can be measured in years is cause for rapture. [Read more]